ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-

β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-

β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- Structure
CAS No.
932042-85-8
Chemical Name:
β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-
Synonyms
Paclitaxel Impurity 41;β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid;Paclitaxel Impurity 13(Paclitaxel EP Impurity M);Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl IMpurity;5β,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,2α,4,7β-tetrahydroxy-9-oxotax-11-en-20-ylbenzoate; β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl];1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20-tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate],;1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate;Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate;Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate]
CBNumber:
CB22622952
Molecular Formula:
C47H53NO15
Molecular Weight:
871.92
MOL File:
932042-85-8.mol
MSDS File:
SDS

β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- Properties

Boiling point 1003.5±65.0 °C(Predicted)
Density 1.41±0.1 g/cm3(Predicted)
pka 11.90±0.20(Predicted)

β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- Chemical Properties,Uses,Production

Uses

An oxetane ring-opened impurity of Paclitaxel (P132500) with no significant activity.

β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 46)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CLEARSYNTH LABS LTD. +91-22-45045900 Hyderabad, India 6351 58 Inquiry
Pharmaffiliates Analytics and Synthetics P. Ltd +91-172-5066494 Haryana, India 6773 58 Inquiry
career henan chemical co +86-0371-86658258 +8613203830695 China 29824 58 Inquiry
China National Standard Pharmaceutical Corporation Limited +8615391658522 China 11927 58 Inquiry
LEAPCHEM CO., LTD. +86-852-30606658 China 43348 58 Inquiry
Henan Fengda Chemical Co., Ltd +86-371-86557731 +86-13613820652 China 20293 58 Inquiry
SHANGHAI KEAN TECHNOLOGY CO., LTD. +8613817748580 China 40067 58 Inquiry
S.Z. PhyStandard Bio-Tech. Co., Ltd. 0755-4000505016 13380397412 China 5056 50 Inquiry
Hubei wei shi reagent group ltd., company 027-02759101766 13125137661 China 4632 58 Inquiry
Shanghai Yihe Biological Technology Co., Ltd. 17721395025 China 3428 58 Inquiry
Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl IMpurity β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester Paclitaxel Impurity 13(Paclitaxel EP Impurity M) Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate Benzenepropanoic acid, β-(benzoylamino)-α-hydroxy-, (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl ester, (αR,βS)- (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocyclodecen-8-yl(αR,βS)-β-(benzoylamino)-α-hydroxybenzenepropanoate Paclitaxel EP Impurity M 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20- tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3- (benzoylamino)-2-hydroxy-3-phenylpropanoate] Paclitaxel Impurity 41 1,2α,4,7β-dihydroxy-9-oxotax-11-ene-5β,10β,13α,20-tetrayl 5,10-diacetate 20-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate], β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8-yl Ester (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-8-(((2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-4-((benzoyloxy)methyl)-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-6,10-methanobenzo[10]annulene-3,11-diyl diacetate (Paclitaxel Impurity) 5β,10β-bis(acetyloxy)-13α-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,2α,4,7β-tetrahydroxy-9-oxotax-11-en-20-ylbenzoate β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl] β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid β-(BenzoylaMino)-α-hydroxybenzenepropanoic Acid (αR,βS)-(1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-Bis(acetyloxy)-4-[(benzoyloxy)Methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetraMethyl-12-oxo-6,10-Methanobenzocyclodecen-8- 932042-85-8 Pharmaceuticals Aromatics Chiral Reagents Heterocycles Impurities Intermediates & Fine Chemicals